Advancing the Prevention and Treatment of Heart Failure: Exploring New Paradigms

Despite rigorous implementation and optimal dosing of guideline-directed medical therapy, a subset of patients with heart failure (HF) remain at high residual risk for complications. This vulnerable group of patients may benefit from a multi-modality approach, consisting of treatment options with different mechanisms of action to help prevent hospitalizations and reduce cardiovascular mortality. 
 
In this symposium, experts discuss current and emerging treatment options for the prevention and treatment of HF, across a spectrum of ejection fractions.

An accredited satellite program, provided by Medscape and supported through an independent educational grant from Bayer U.S.